LOC727853 Inhibitors

Wortmannin and LY294002 are PI3K inhibitors that can block the PI3K/AKT pathway, which is a critical regulator of numerous cellular functions and may govern the activity of LOC727853. Triciribine, by specifically targeting AKT, can prevent the activation of downstream signaling that impacts LOC727853. SP600125 and SB203580 target JNK and p38 MAPK, respectively, and can disrupt the respective signaling pathways that may be relevant to LOC727853's role within the cell.

U0126 and PD98059 are MEK inhibitors that block the MAPK/ERK pathway, a critical signaling cascade that can have a broad impact on cellular processes, including those associated with LOC727853. PP2, as a Src family kinase inhibitor, can affect cellular communication and signaling involving LOC727853. PD 0332991 hydrochloride role as a CDK4/6 inhibitor implicates it in cell cycle control, which may intersect with LOC727853's function. Rapamycin, an mTOR inhibitor, and Bortezomib, a proteasome inhibitor, can regulate protein synthesis and degradation pathways that include LOC727853. ZM-447439, an inhibitor of Aurora kinases, can disrupt cell division, which may affect the processes regulated by LOC727853.